Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810990 | SCV000603224 | benign | not provided | 2024-11-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000537145 | SCV000652492 | benign | Immunodeficiency, common variable, 7 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001810990 | SCV002562977 | benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | CR2: BP4, BP7, BS1, BS2 |
Fulgent Genetics, |
RCV002481636 | SCV002795314 | likely benign | Systemic lupus erythematosus, susceptibility to, 9; Immunodeficiency, common variable, 2; Immunodeficiency, common variable, 7 | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000537145 | SCV004180407 | benign | Immunodeficiency, common variable, 7 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001810990 | SCV005284817 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004551643 | SCV004754467 | benign | CR2-related disorder | 2019-03-04 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |